📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
77
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ATGL.
💹 Market Data
Market Cap$233.77M
Shares Outstanding15.26M
Float2.67M
Cash$3.96M
Debt$638.7K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 97.5% shares (2025Q4 vs prior)
2 institutional holders · 313 shares
#1
WELLS FARGO & COMPANY/MN
175 shares
#2
UBS Group AG
138 shares
📉 Short Interest
Short Interest15.7K
Days to Cover16.1
% of Float0.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for ATGL
📊 ATGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ATGL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.